Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion

INTRODUCTION: To investigate treatment outcomes after switching from ranibizumab to aflibercept intravitreal injections in patients with macular oedema (MO) secondary to branch retinal vein occlusion (BRVO). METHODS: Eligible patients with refractory MO secondary to BRVO, post treatment with a minim...

Descripción completa

Detalles Bibliográficos
Autores principales: Konidaris, Vasileios E., Tsaousis, Konstantinos T., Anzidei, Rossella, de la Mata, Guillermo, Brent, Alexander J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258582/
https://www.ncbi.nlm.nih.gov/pubmed/30288685
http://dx.doi.org/10.1007/s40123-018-0149-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258582/
https://www.ncbi.nlm.nih.gov/pubmed/30288685
http://dx.doi.org/10.1007/s40123-018-0149-3

Ejemplares similares